HIV prevention in the United States : New opportunities, new expectations
Published Date:December 2015
Description:Section 1. Introduction -- ￼￼section 2. Status of HIV in the United States -- Section 3. CDCs current HIV prevention priorities -- Section 4. Additional strategies -- Section 5. Critical gaps and advances to come -- ￼￼section 6. References
The power of HIV prevention is clear. Studies show that our nation’s prevention efforts have averted hundreds of thousands of HIV infections, saving many lives and billions of dollars in medical costs since the early years of the epidemic.
Now we have the tools to achieve an even greater impact. Recent scientific breakthroughs have equipped us with prevention options that can greatly reduce new infections, illness, and deaths from HIV (see sidebar). Some are just beginning to reach people who can benefit, while others – most notably, antiretroviral therapy (ART) for people with HIV – are widely available but not being used to their full potential.
Faster progress depends on our collective ability to take full advantage of these tools in every community and every region of the country. This will require:
• Thinking in new ways. HIV prevention and treatment have often been thought of as separate priorities. Now that research has proven that treatment for people living with HIV dramatically reduces the risk of HIV transmission, supporting outcomes along the HIV care continuum must be a core priority of prevention efforts.
• Focusing on what works. With limited resources, we need to prioritize strategies that are shown to have the greatest potential impact – and set aside those that are less cost-effective or cannot be delivered on a large scale.
• Confronting barriers to prevention. We need to boldly address stigma, discrimination, and other social, economic, and structural issues that increase vulnerability to HIV and come between people and the care they need.
• Preparing for the future. Even as we increase access to existing prevention tools, we need to prepare for tomorrow’s advances – from more advanced HIV tests to long-acting formulations of treatment and pre-exposure prophylaxis (PrEP) – so that people can benefit quickly.
Supporting Files:No Additional Files
You May Also Like: